Start of our first completely digital decentralized clinical trial of an innovative DiGA

Completely digital clinical studies at MEDIACC: innovative, efficient and people-oriented through cutting-edge technology

MEDIACC is defining the future of digital clinical trials by implementing international laws and recommendations, in particular the EMA guideline for computer-based systems, for clinical trials.

In a lighthouse project, we successfully carried out a completely digital study, which recruited over 2000 study participants to test an innovative health app using a telemedicine approach. The digital study platform integrates an electronic data collection system (EDC) with additional digital modules and newly thought-out proven processes to ensure the highest quality and reliability of study data in an excellent study design. Automatic processing and validation controls and data management are just a few aspects that inspire us.

In doing so, we preserve the rights, dignity and safety and ensure the well-being of study participants. At the same time, this enables us to continue working for efficiency and excellence, decent working conditions and improved medical care. The established and certified standards are now being transferred to the next digital decentralized studies for important medical devices. Our high security measures are always risk-based, adapted to the individual requirements of each study and implement the high European requirements for data security and data protection.

Would you like to shape the future of clinical trials? If you want to be part of this scalable development, we offer you the ideal solution for your clinical trial.

‍

An overview of our current studies can be found here: https://www.mediacc.de/studien/aktuelle-studien-fur-studieninteressierte